Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PADMAVATHI V PAGADALA

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1174683544
CMS profile
767027
Location
CUMMING, GA

General Payments · PY2018

$375.42

  • Reported across 19 records
  • CMS publication 2026-01-23

Latest program year · PY2018

$375.42

19 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2018 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $349.08 16
Education $26.34 3

By paying entity

PY2018 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $375.42 19

Payment records · PY2018 (19)

Sorted by paying entity, then date · as published by CMS

Program year 2018
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AMAG Pharmaceuticals, Inc. $15.59 01/03/2018 Education Undisputed 01/23/2026 559519277 CMS
AMAG Pharmaceuticals, Inc. $122.07 01/23/2018 Food and Beverage Undisputed 01/23/2026 559519279 CMS
AMAG Pharmaceuticals, Inc. $7.27 03/20/2018 Education Undisputed 01/23/2026 559519281 CMS
AMAG Pharmaceuticals, Inc. $3.48 05/16/2018 Education Undisputed 01/23/2026 559519283 CMS
Amgen Inc. $16.21 02/06/2018 Food and Beverage Undisputed 01/23/2026 567796461 CMS
Amgen Inc. $14.04 03/01/2018 Food and Beverage Undisputed 01/23/2026 567796471 CMS
Amgen Inc. $12.46 04/17/2018 Food and Beverage Undisputed 01/23/2026 567796477 CMS
Amgen Inc. $13.59 05/30/2018 Food and Beverage Undisputed 01/23/2026 567796483 CMS
Bayer HealthCare Pharmaceuticals Inc. $21.54 02/02/2018 Food and Beverage Undisputed 01/23/2026 537162393 CMS
Bayer HealthCare Pharmaceuticals Inc. $15.58 04/26/2018 Food and Beverage Undisputed 01/23/2026 537073367 CMS
Bayer HealthCare Pharmaceuticals Inc. $10.66 06/07/2018 Food and Beverage Undisputed 01/23/2026 537089115 CMS
Covidien LP $24.46 03/15/2018 Food and Beverage Undisputed 01/23/2026 565081982 CMS
Merck Sharp & Dohme Corporation $16.17 01/29/2018 Food and Beverage Undisputed 01/23/2026 604206061 CMS
Merck Sharp & Dohme Corporation $16.11 05/02/2018 Food and Beverage Undisputed 01/23/2026 604399075 CMS
Mylan Pharmaceuticals Inc. $11.15 01/23/2018 Food and Beverage Undisputed 01/23/2026 605285007 CMS
Mylan Pharmaceuticals Inc. $10.71 02/01/2018 Food and Beverage Undisputed 01/23/2026 605285855 CMS
Novum Pharma, LLC $11.16 05/30/2018 Food and Beverage Undisputed 01/23/2026 617839401 CMS
Novum Pharma, LLC $12.69 09/10/2018 Food and Beverage Undisputed 01/23/2026 617839403 CMS
Vertical Pharmaceuticals, LLC $20.48 02/07/2018 Food and Beverage Undisputed 01/23/2026 603611331 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018
Source files
Dataset page · Bulk file · PY2018
Generated from
OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.